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Kidney transplant outcomes may be determined as the time at which 
glomerular filtration rate (GFR) <45 ml/min|1.73m2, as an indicator of poor 
transplant prognosis. We aimed to characterize these outcomes after transplant 
in the Chronic Kidney Disease in Children (CKiD) cohort. For a substantial 
proportion of children, their first GFR was observed to be below 45 ml/min and 
this occurred at heterogeneous times after transplant. Using data from 143 
children who received a transplant and contributed GFR data, for 24 the time 
when GFR<45 ml/min was determined by interpolation between two 
observations above and below this threshold; 18 had a first GFR<45 ml/min 
and were classified as prevalent events and the remaining 101 participants 
contributed GFR>45 ml/min. To impute times for the prevalent events, we 
used a two-stage model approach that may be applied to other settings in 
which trajectories of biomarkers define events. The first model aimed to 
determine level of GFR shortly after transplantation (0.25 years) using 
empirical Bayes estimates of the intercept and slope from linear mixed models 
with GFR as the dependent variable and time as the independent variable 
among children who contributed GFR data within 1 year after transplantation. 
The empirical Bayes estimates provided the estimated levels of GFR at 0.25 
years after transplant. Using these data as the outcome and pre-transplant 
variables as the predictors, we then constructed an imputation model to 
determine GFR levels among prevalent cases. For 18 prevalent cases, the time 
when GFR<45ml/min was interpolated from the imputed value at 0.25 years 
 iii 
and the first observed GFR<45ml/min. This proposed approach used a 
combination of observed data, empirical Bayes estimates and imputed values 
to estimate time to event for all individuals and was less biased compared to a 
simple cumulative incidence approach which does not account for 
heterogeneous follow-up time. 
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Kidney transplant has become the preferred treatment modality for end-stage 
renal disease (ESRD) among children during the last decade. Therefore, 
determining risk factors prior to ESRD that are related to poor pediatric kidney 
transplant outcome is an area of high priority. To address this important 
research question in clinical cohorts, a valid study endpoint for middle to long-
term pediatric kidney transplant outcome is crucial.  Based on previous 
studies, kidney transplant outcome can be determined as the time at which 
glomerular filtration rate (eGFR) below a clinically meaningful threshold value, 
as an indicator of poor transplant prognosis in epidemiological studies. In this 
study, we aimed to characterize an outcome of time to low eGFR event by 
imputing an starting value after transplant in the Chronic Kidney Disease in 
Children (CKiD) cohort, in order to resolve the methodological challenge due to 
heterogeneous follow-up time. 
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Kidney transplant has become the preferred treatment modality for end-stage 
renal disease (ESRD) among children, adolescents and young adults during the 
last decade based on USRDS data. Between 2010-2014, 36% of children with 
ESRD received a kidney transplant within the first year of medical care (1). In 
addition, approximately 800 renal transplants are performed in children below 
18 years of age annually in the United States (2). Therefore, determining factors 
prior to ESRD that are related to poor kidney transplant outcome in children is 
an area of high priority. To better address this research topic, a study endpoint 
that can well represent the risk of having poor transplant outcome will be of 
importance.  
Renal graft failure defined as either re-transplantation or return to dialysis has 
been commonly used as the primary measure of poor kidney transplant 
outcome in previous studies. However, renal graft failure may not be able to 
detect the risk of having unfavorable outcome in a preemptive manner so that 
intervention could be applied earlier.  A recent study has shown that estimated 
glomerular filtration rate (eGFR) calculated by a serum creatinine-based 
formula performed well in measuring post-transplant kidney function in 
children having received a kidney transplant (3). Additionally, it has been 
shown that post-transplant renal function measured by serum creatinine can 
predict long-term renal graft failure among adults (4). Based on these findings, 




outcome determined by a serum creatinine-based eGFR level would be helpful 
as a research endpoint in pediatric chronic kidney disease (CKD) research.  
In this study, we seek to characterize the kidney transplant outcome in 
children by using time from initiation of transplant to a low eGFR event that 
was defined based on a threshold value of 45 ml/min|1.73 m2. However, in 
cohort studies where eGFR values are longitudinally collected at follow-up 
visits that occurred at heterogeneous time after transplant, some participants 
may be first observed an eGFR below the threshold. These participants are 
referred as having a prevalent event and would have been excluded from 
further analysis. The Chronic Kidney Disease in Children (CKiD) study is well 
positioned to address this methodological challenge. It is a prospective cohort 
aimed at investigating pediatric CKD progression. In the original CKiD cohort, 
detailed phenotyping data before kidney transplant was well collected by close 
follow-up visits. However, post-transplant data collection was not initiated until 
a later time, by which a proportion of existing participants had already received 
transplant for a substantial period of time and developed a prevalent event. To 
resolve this practical problem that might also be seen in other cohorts, our 
study proposed a method to impute the missing eGFR levels the study failed to 
capture at an earlier time after transplant, and to estimate time to the low 







Study design and participants  
The Chronic Kidney Disease in Children (CKiD) Study is a multicenter, 
prospective cohort study conducted at 54 pediatric nephrology centers across 
North America with the primary aim to determine risk factors for decline in 
renal function and progression of chronic kidney disease (CKD) in children. 
Details of the CKiD design have been previously published (3). Briefly, eligible 
children were between 1 and 16 years with mild to moderate CKD based on an 
estimated GFR of 30-90 mL/min/1.73 m2 (9).  Regular study visits occurred 
annually until the initiation of renal replacement therapy (RRT, dialysis or 
kidney transplant). At regular visits, data were collected on kidney function, 
cardiovascular health, neurocognitive development, growth, and self-reported 
medical history and socioeconomic factors. Regular visits ceased after 
documented initiation of RRT but participants could participate in short study 
visits in which self-reported general health, eGFR levels and clinical events 
were collected by telephone or in-person (PIP) interviews. The study protocol 
was approved by the institutional review board of each participating center, 
and participants and their families provided informed consent. From January 
2005 through December 2015, a total of 891 participants were enrolled in 
CKiD study. The present analysis was limited to participants who received 





Time to event outcome 
To better characterize poor kidney transplant prognosis based on a meaningful 
threshold value of GFR, we suggested a time to event outcome that could 
account for the length of time from transplant to the first occurrence of a low 
eGFR value. 
The outcome of interest was time from the initiation of kidney transplantation 
to the date when eGFR < 45 ml/min|1.73 m2. Previous studies have shown 
that eGFR is a valid measure of kidney function in pediatric kidney transplant 
recipients (1), though it may be unstable shortly after the initiation of 
transplantation. Thus, we anchor the time origin at 0.25 years after transplant 
in order to allow for a period of GFR stabilization. Observed eGFR < 45 
ml/min|1.73m2 within 0.25 years after transplant was not considered as an 
indication of poor transplant outcome because it may be highly variable 
between individuals and measurements due to delayed allograft function (8), 
human leukocyte antigen (HLA) compatibility (10), acute rejection (8), type of 
kidney (7), or medical center factors (2). The eGFR levels after transplant were 
obtained by PIP interviews using self- or parent-reported information from the 
most recent clinical examination. A validated equation derived from CKiD 
population was used to estimate these GFR values based on serum creatinine, 
cystatin C, blood urea nitrogen, height and gender (9). As a measure of poor 
transplant prognosis and one of secondary outcomes in CKiD study, this time 




transplant. Thus, we only observed a period during which the eGFR trajectory 
declined to a level below 45 ml/min|1.73m2 among those individuals having 
the poor transplant prognosis. More importantly, 42% (n=18) of all children 
with poor transplant prognosis had their first eGFR observation after 
transplant below 45 ml/min due to a delayed PIP interview. They were referred 
as having prevalent events since we could only observe a partial trajectory of 
post-transplant eGFR after they had already developed the low eGFR event. For 
children with prevalent event, at least another eGFR value before their first 
post-transplant eGFR observation was needed in order to determine their event 
time. Therefore, we were going to impute a starting value of eGFR shortly after 
they had received kidney transplant and then estimate the event time based on 
this imputed value.  
 
Pre-transplant variables 
The pre-transplant variables that were used to estimate the time to event 
outcome including age, race, primary CKD diagnosis, eGFR level, annualized 
eGFR ratio, urine protein-creatinine ratio (uP/C), BMI, height, and 
socioeconomic status (SES) at study enrollment. CKD diagnosis was 
dichotomized as either having an underlying glomerular or non-glomerular 
cause (11). eGFR levels were longitudinally collected at each regular visit from 
study enrollment until the initiation of kidney transplantation using the same 




measurements. The annualized eGFR ratio, as a metric of kidney function 
decline, was defined as 
𝐺𝐹𝑅𝑣𝑖 𝐺𝐹𝑅𝑉𝑖−1⁄
𝑡𝑖𝑚𝑒𝑣𝑖  − 𝑡𝑖𝑚𝑒𝑣𝑖−1
, where time was in years. Specifically, we 
fitted individual-specific linear regressions where time from study enrollment 
was the predictor and log eGFR was the dependent variable using eGFR values 
across all time points prior to transplant (6). Urine protein and creatinine were 
measured centrally in the laboratory at University of Rochester (12). BMI and 
height Z-scores were standardized by age and gender from the normal 
population. Participants and their parents were asked to report household 
income level, maternal education status (having vs. not having a college 
degree), medical insurance types (private vs. public), and whether they had 
received social worker or food assistance in the past 12 months, as a proxy of 
socioeconomic status.  
 
Statistical analysis 
Since the low eGFR event was determined by the threshold limit of 45 
ml/min|1.73m2, the methodological problem was that of prevalent events (i.e., 
first post-transplant eGFR observation < 45 ml/min) into the cohort. We 
sought to develop a method to impute the eGFR starting value at 0.25 years 
after transplant so that the prevalent events can be included as informative 
cases in our analysis. The proposed method includes three steps.  




The first model aimed to determine level of eGFR at 0.25 years after transplant 
using the empirical Bayes estimates for each individual. To obtain the 
empirical Bayes estimates, we applied a linear mixed effects model, which 
allowed for random intercepts and slopes of eGFR over time to deviate from the 
population means among children who contributed eGFR data within 1 year 
from transplant. We centered time at 0.25 years from transplant so that the 
empirical Bayes estimate of intercept could be easily converted to the eGFR 
starting value. Specifically, this model was of the form: 
log(𝑒𝐺𝐹𝑅)𝑖𝑗 = (𝛼 +  𝑎𝑖) + (𝛽 +  𝑏𝑖) ∗ 𝑡𝑖𝑚𝑒𝑖𝑗 +  𝜀𝑖𝑗 
where                             (
𝑎𝑖
𝑏𝑖







2 )]           𝜀𝑖𝑗   ~  𝑁( 0, 𝜎
2) 
Here, we use α and β to denote the population intercept and slope, respectively. 
In the equation, 𝑎𝑖 and 𝑏𝑖 are the random intercept and slope, respectively, for 
the ith individual. The 𝜀𝑖𝑗 is the Gaussian error term for the jth observation of 
the ith individual. Time in the model was specified to be anchored at 0.25 years 
after transplant. The covariance matrix was modeled to be unstructured. After 
fitting the mixed liner model, we used the predict command with the reffects 
option in Stata to obtain the empirical Bayes estimates of individual intercept. 
Lastly, we took the exponential of this value and obtained the eGFR starting 
value at 0.25 years after transplant. However, the eGFR starting value imputed 
by empirical Bayes estimates were only available for those children who have at 




Step 2: multivariate linear regression model with pre-transplant variables as 
predictors 
For children who had no eGFR observation within 1 year from transplant but 
contributed data at some later time, a multivariate linear regression (MLR) 
model was used to impute their eGFR level at 0.25 years after transplant. The 
MLR model was informed by the empirical Bayes estimates and the pre-
transplant variables at study enrollment including age, race, CKD diagnosis, 
log-transformed eGFR level, annualized eGFR ratio, log-transformed uP/C, BMI 
Z-score, height Z-score, and socioeconomic status. Specifically, we estimated 
the parameters of the MLR model where the log-transformed eGFR starting 
value obtained in step 1 was the dependent variable and pre-transplant 
variables were predictors. We then took the expected value of log(eGFR) at 0.25 
years for a given profile of predictors as the best estimation and then 
transformed the value back to arithmetic scale. Therefore, for children without 
eGFR observation within 1 year from transplant, their eGFR starting values 
were imputed by MLR model.  
Step 3: Determine time from transplant to the low eGFR (< 45 ml/min|1.73m2) 
event  
We assumed a linear relationship within each adjacent pair of eGFR values, 
and used the combination of imputed and observed values to interpolate the 
time at which eGFR < 45 ml/min. The time of prevalent event was interpolated 




time of incident event (i.e., having at least one observation before the first 
observed eGFR below 45 ml/min) was imputed based on two observed data 
points between which the event occurred. Children who had no observed eGFR 
< 45 ml/min were censored at their last visit. We excluded children whose 
imputed eGFR starting value at 0.25 years was less than 45 ml/min because 
they were not at risk for our event of interest. 
We described the imputed eGFR starting values stratified by imputation 
methods, as well as the median and interquartile range of estimated event 
times. The estimated time to low eGFR event, as a measure of poor kidney 
transplant outcome, was graphically presented by the Kaplan-Meier survival 
curves with 95% confidence bands. We also compared the 25th percentile and 
50th percentile of event times among population including (N=143) versus 
excluding (N=125) the prevalent events. All analyses were conducted using 
STATA/SE 13.1 (Statacorp LP) and SAS 9.4 (SAS Institute, Inc.). Graphic 
figures were constructed using R statistical software 3.1.2 (R Foundation for 










Of 891 children enrolled in CKiD, 192 children received a kidney transplant. Of 
these, 155 children had at least one estimated GFR observation after 
transplant. Table 1 presents the descriptive statistics of pre-transplant 
demographic, clinical, growth and socioeconomic characteristics of these 155 
children at study enrollment. The median age at transplant was 15 years. Most 
children were diagnosed with non-glomerular CKD (72%). The median 
estimated GFR was 36.5 ml/min|1.73 m2 and over two thirds of the study 
population had either elevated or nephrotic proteinuria at study enrollment. In 
addition, these 155 children had on average lower height and weight compared 
to normal population; 68% had a maternal education less than college degree 
and 40% were from low-income families.   
Among 155 children who contributed eGFR observations after transplant, 3 
children only had one GFR observation within 0.25 years from receiving a 
transplant. They were excluded in the further analysis because eGFR level 
within this short time after transplant may be unstable and not predictive of 
long-term outcomes. Table 2 shows the length of time from transplant to the 
first eGFR observation collected. For those children whose first observed eGFR 
was greater than 45 ml/min, the median time from transplant to the first 
observation was 0.9 years. Among children with the first observed eGFR less 
than or equal to 45 ml/min, median time after transplant at which this first 




missing data problem. In other words, it was very likely that because the longer 
period between transplant and the PIP visit allowed time for kidney function to 
deteriorate, we observed a low eGFR as the first available record. If we could 
capture eGFR data earlier, we might observe a higher value before the first 
available record. To address this missing data problem, we used a linear mixed 
effects model (step 1) and MLR (step 2) to impute a starting eGFR value at 0.25 
years after transplant. 
In step 1, the linear mixed effect model was performed on 80 children 
contributing a total of 90 eGFR observations within 1 year from transplant. 
Table 3 presents the data and parameter estimates for the linear mixed effect 
model. When we centered time at 0.25 years after transplant, the intercept of 
the linear mixed effect model with log(eGFR) as the dependent variables was 
4.03. This intercept corresponds to a population average eGFR level of 56.3 
ml/min at 0.25 years after transplant. The slope of the same mixed effects 
model was 0.12 (95%CI: -0.06, 0.31), which suggests that on average, the eGFR 
was 13% higher one year after receiving transplant among these 80 children 
(13%=(exp(0.12)-1)*100%). For the remaining 72 children, we used MLR model 
with pre-transplant variables as predictors to impute their eGFR starting 
values (i.e., eGFR at 0.25 years after transplant) in step 2. Table 4 shows the 
parameter estimates for the MLR model.  
After we obtained the eGFR starting values for each individual, we summarized 




imputation methods (Table 5). The medians of imputed eGFR at 0.25 years 
after transplant were similar between empirical Bayes estimates and MLR 
model, both at about 58 ml/min. The eGFR starting values imputed by 
empirical Bayes estimates have a wider interquartile range comparing to those 
imputed by MLR, however the difference was minimal.   
In step 3, we classified individuals into four categories based on the patterns of 
eGFR trajectory: 1) incident event, 2) prevalent event, 3) censored, and 4) 
excluded. We then applied a category-specific approach to estimate their time 
to low eGFR event or censoring. 
Category 1: Incident event (n=24) 
We defined the incident event as having at least one observation before a first 
observed eGFR that was less than 45 ml/min. In our study population, 24 
children (17%) were classified as having an incident event. Figure 1 shows the 
post-transplant eGFR trajectories of 5 children as examples. For these 
children, their event times were determined by assuming a linear relationship 
between two adjacent eGFR observations, one was above 45 min/ml, and the 
other was below. In figure 1.1, there were 6 eGFR observations and an imputed 
staring value for the example child. Of all observed values, one was within 0.25 
years from transplant and five were after. Coincidentally, the fourth 
observation after 0.25 years from transplant was collected at a level very close 
to the threshold of 45 ml/min. Thus, the estimated event time was similar to 




figure 1.2 and figure 1.4, the interpolation yielded more accurate estimations of 
event time comparing to only using the observed times.  
Category 2: Prevalent event (n=18) 
We defined the prevalent event as having the first post-transplant eGFR 
observation less than 45 ml/min. Notably, 42% of events defined as eGFR < 45 
ml/min and 13% of participants in our study population had a prevalent event. 
Figure 2 shows 5 examples of eGFR trajectories for children having prevalent 
event. The event times were interpolated by the imputed eGFR starting value 
and the first eGFR observation after transplant. The starting values were either 
imputed by empirical Bayes estimates (figure 2.1 and 2.2) or by multiple linear 
regression model (figure 2.3 through 2.5). Most of imputed starting values were 
consistent with the overall linear trend characterized by later observed values, 
regardless of the imputation method was used. In figure 2.3, the first eGFR 
observation after transplant was just slightly less than the threshold value of 
45 ml/min, and its trajectory increased later. In this case, our estimation may 
not be as accurate as in figure 2.4 and figure 2.5. However, the prevalent 
events would have been excluded if the starting value was not imputed, which 
could lead to a huge loss in statistical power due to limited numbers of events.  
Category 3: Censored (n=101) 
There were 101 children (71%) who never experienced an eGFR less than 45 
ml/min during PIP follow-ups after transplant, and thus were censored at their 




followed for one or two years, and then had loss to follow-up. It was possible 
that they developed events later, though we had not been able to capture them. 
If we only used cumulative incidence counts as the outcome, they would have 
been classified as not having event, which might biased further analysis. By 
censoring them at the last visit, we take the person-time contributed by these 
children into account and maximize the use of available information.    
Category 4: Excluded (n=9) 
We excluded 9 children (6%) whose imputed eGFR starting value at 0.25 years 
after transplant was less than or equal to 45 ml/min|1.73 m2. Figure 4 shows 
the trajectories of 5 children as examples. Because the outcome of interest was 
defined based on an eGFR threshold value of 45 ml/min, children with an 
imputed starting value less than 45 ml/min were not considered as being at 
risk of the event. Although some of children’s eGFR had increased to a level 
greater than the threshold and had a recurrent low eGFR afterward (for 
example, figure 4.5), they did not contribute person time in this analysis.  
Table 6 presents the medians and interquartile ranges of time from transplant 
to the low eGFR event or censoring that were estimated by proposed method. 
Overall, half of events occurred before 2.4 years after transplant and half of 
non-events were censored before 2.8 years after transplant. Based on our 
method, the median of estimated time when eGFR declined to a level less than 
45 ml/min was earlier among children having prevalent event (1.2 years, IQR: 




3.6]). The earlier times among prevalent events may reflect a systematic 
difference in disease severity. It was likely that children with prevalent events 
tend to be sicker and need intensive care, which prevented them from being 
accessed by telephone contacts. However, we cannot exclude the possibility 
that our methods tend to underestimate the prevalent event time (i.e., define an 
earlier event time than if multiple eGFR values were observed leading up to it) 
because of the linear interpolation between two data points. 
Figure 5a presents the Kaplan-Meier curve and the 95% confidence band 
among 143 children included in our analysis. The estimated time at which 25% 
and 50% of population had experienced a low eGFR event based on proposed 
method were 3.1 and 6.6 years after transplant, respectively. In contrast, if we 
performed a naïve analysis and excluded prevalent events (n=125), the time at 
which 25% population had experienced an eGFR< 45 ml/min would have been 
4.2 years and the median would have been unspecified due to limited number 
of events.  
The data structure is now set up to investigate putative risk factors for time to 
eGFR < 45 ml/min after a kidney transplant in order to identify modifiable 








Glomerular filtration rate (GFR) is a biomarker that has been widely used in 
epidemiological studies related to pediatric nephrology. Multiple formulas for 
calculating eGFR have been developed and validated in different setting (14). In 
this study, we used the eGFR values calculated by the CKiD 2012 equation. 
This serum creatinine-based equation has been shown to perform well in 
measuring post-transplant kidney function at measured GFR < 90 
ml/min|1.73 m2 among pediatric kidney transplant recipients (3). Based on 
the KIDGO 2012 Clinical Practice Guideline (15), GFR < 45 ml/min|1.73 m2 
was suggested to be used as the threshold value to classify mildly to 
moderately decreased kidney function (Stage G3a) as this level is related to 
substantially increased risk in kidney failure, cardiovascular mortality, and 
acute kidney injury. The present study defined the low GFR event as the first 
occurrence of an observed eGFR < 45 ml/min after transplant to assess poor 
kidney transplant outcome. Comparing to other approaches that may require 
intensive clinical or laboratory examinations, this low eGFR event is more 
feasible to be applied in large cohort studies as a surrogate for poor transplant 
outcome and a potential clinically relevant endpoint prior to graft failure.  
When defining the occurrence of a clinical event based on a threshold value of 
a biomarker in longitudinal studies, missing values in some repeated 
measurements of the biomarker may prevent us from observing the exact event 




at heterogeneous times. For children whose post-transplant PIP visits occurred 
well after transplant, their first eGFR observations after transplant tended to be 
lower. This was likely due to the longer time period from transplant to the PIP 
visit had allowed us to observe the deterioration of their kidney function after a 
temporary improvement resulting from transplant. In addition, as the 
secondary outcome, post-transplant kidney function was collected mainly by 
telephone contact. For children with worse kidney function after having 
transplant, they may need intensive care during which we could not reach 
them by phone calls. Therefore, the missing data that should have been 
collected at scheduled PIP visits created an absence of data at a critical time. 
This resulted in a substantial proportion of children in the cohort were 
observed having a prevalent event.   
To resolve this methodological problem, we proposed an approach to determine 
the low eGFR event time using a combination of observed data and imputed 
starting values obtained by empirical Bayes techniques or multivariate linear 
regression. Empirical Bayes estimates derived from linear mixed effects models 
are conventional tools for characterizing linear trajectories of biomarkers 
measured repeatedly over time in individuals. It was obtained by the relative 
weighting of the individual eGFR observations collected during PIP visits, and 
the population means of eGFR trajectory that were informed by the parameter 
values of mixed effects model.  As the eGFR level may change over time after 
having transplant, we restricted to observations within one year from 




eGFR starting value. However, most children who contributed observations to 
the mixed effects model had only a single data point during the one-year time 
window. Taking the advantage of empirical Bayes estimates, child-specific 
slopes can be estimated as closely linked to the population average slope, 
which allowed us to impute their eGFR starting value at 0.25 years after 
transplant without introducing external information. For children having no 
eGFR observations during the one-year time window, we used pre-transplant 
information to impute their eGFR starting values. It is worth mentioning that 
although these imputed starting values are informed by pre-transplant factors, 
they are still valid to be used as a component for constructing the time to event 
outcome in studies where these pre-transplant factors may also serve as 
exposures of interest. Since the event time is mainly determined by later eGFR 
observations, investigating the relationship between this time to event outcome 
and the pre-transplant factors that are both the exposures, and at the same 
time, involved in the imputation process are assumed to be valid.  
There were several advantages to using the time to low eGFR event estimated 
by proposed method as a measure of poor kidney transplant outcome in cohort 
studies. First, it allowed us to maximize the data by imputing an eGFR starting 
value for children with prevalent event and including them in further analysis. 
It is crucial to maximize the data and increase statistical power since the 
pediatric kidney transplant is a relatively rare condition. Second, compared to 
using a cumulative incidence approach as the measure of poor kidney 




transplant eGFRs collected at heterogeneous times across individuals into a 
homogeneous binary variable. Here, the poor transplant outcome is defined by 
eGFR level that may change over time, and children with longer follow-up time 
after transplant were more likely to observe an eGFR < 45 ml/min. The 
proposed method properly accounts for the loss to follow-up in the longitudinal 
study design and maximize the available information by including time as a 
component for measuring poor kidney transplant outcome. Based on this 
outcome, a wide range of survival analysis techniques can be easily applied. 
Lastly, although this method was motivated by the methodological challenge we 
have encountered in the context of pediatric transplant, it can be also 
generalized to other settings in which thresholds of biomarkers define events 
and prevalent events are common due to heterogeneous follow-up time. The 
length of time window that were used to impute starting values, the time origin 
at which events were anchored to ensure stable biomarker levels, and the 
threshold value for defining the event of interest are all modifiable and can be 
optimized based on different purposes.  
This study had several limitations. First, when building the MLR model to 
impute the eGFR starting values for children having no eGFR observations 
within one year from transplant, we used the eGFR starting values obtained by 
empirical Bayes estimates as the dependent variable. By doing this, we 
assumed a same relationship between pre-transplant factors and the eGFR 
starting values among children with and without eGFR observations within one 




children having no data during the first year are also likely to be sicker. 
Therefore, the parameter estimates of the MLR model may be affected by 
potential selection bias, and will not result in an accurate prediction for the 
other subset of children. Second, the proposed method may underestimate the 
event time for prevalent events because of the interpolation using two data 
points. Figure 1.2 may serve as a good example to illustrate what the estimated 
event time would have been if we failed to observed the first two data points 
after transplant. In that case, we would have to interpolate event time use the 
imputed starting value at 0.25 years and the first eGFR observation below 45 
ml/min (i.e., the third observation). And the estimated event time would be 
around 1 year after transplant instead of 2 years as shown in the graph. Third, 
we only used a single imputation by the MLR model. The proposed approach 
can be potentially extended to multiple imputations that can incorporate valid 
estimation of uncertainty. Lastly, we anchored the event time at 0.25 years 
after transplant in order to allow enough time for eGFR level after transplant to 
stabilize. It is possible that pediatric kidney transplant recipients need more 
time than this for the stabilization of eGFR level. It might be worthy to 
investigate another time origin in further studies in order to obtain a more 
robust estimation.  
In summary, we suggested a sequential approach to impute eGFR levels shortly 
after kidney transplant and characterize poor kidney transplant outcome as the 
time to low eGFR event for pediatric recipients in cohort studies. This provides 




of biomarkers, in which prevalent events determined by a threshold of this 
biomarker can be included in further analysis. The proposed method can be 
applied in other settings, and may serve as an initiate template of resolving 














Table 1. Descriptive statistics of pre-transplant characteristics at study 
enrollment among children who had at least one estimated GFR 
observations after transplant  (N=155) 
 Median [IQR] or % (N) 
Demographic characteristics  
Male 63% (97) 
Race   
 White 67% (104) 
 Black 20% (31) 
 Other 13% (20) 
Age at transplant (year) 15.0 [12.5, 17.1] 
CKD duration at transplant (year) 12.9 [8.8, 16.4] 
Time from study entry to transplant (year) 3.7 [1.8, 6.0] 
  
Clinical characteristics  
Non-glomerular CKD diagnosis 72% (112) 
Estimated GFR (ml/min|1.73 m2) 36.5 [30.9, 44.4] 
Annual change in eGFR prior to transplant -15.5% [-25.1%, -8.6%] 




 Minimal (< 0.2 mg/mg of Cr) 30% (45) 
 Elevated (0.2 to 2 mg/mg of Cr) 38% (56) 
 Nephrotic (> 2 mg/mg of Cr) 32% (48) 
Uncontrolled hypertension 54% (82) 
  
Growth characteristics   
Abnormal birth history (premature, low birth 
weight or small gestational age) 
27% (39) 
Height z-score  -0.8 [-1.7, 0.1] 
Weight z-score  -0.2 [-1.2, 0.8] 
BMI z-score 0.5 [-0.4, 1.2] 
  
Socioeconomic characteristics  
Maternal education less than college degree 68% (103) 
Household income <$36K per year 40% (61) 
Food assistance in past year 17% (26) 
Any public insurance 47% (69) 
Abbreviations: IQR, interquartile range; %, percentage; N, number; GFR, glomerular filtration rate; 
CKD, chronic kidney disease. Median [IQR] for continuous variables and %(N) for categorical 
variables. Height, weight, and BMI z-scores were based on the normal population and standardized 







Table 2. Time of eGFR values observed from transplantation 
stratified by first eGFR observation greater or less than 45 
ml/min/1.73 m2, median [IQR] 
 
 
1st observed eGFR  
> 45 
(N=125) 
1st observed eGFR 
<= 45 
(N=27) 
Time from transplant to 
1st eGFR observation, yr 
0.91 [0.48, 2.14] 2.70 [0.71, 3.51] 
Time from transplant to 
last eGFR observation, 
yr 
3.19 [1.84, 5.78] 4.13 [1.84, 6.57] 
Abbreviations: eGFR, estimated glomerular filtration rate; IQR, interquartile range; N, 
number; yr, years after transplant 
Table 3. Data and parameters for linear mixed model among children 
having eGFR observations within 1 years after transplant, (95% CI) 
Number of subjects  80 
Number of observations in total 90 
Number of children contributed  
One observation     71 
  Two observations 8 
     Three observations 1 
  
Population intercept (log scale, centered) 4.03 (3.94, 4.13) 
Average eGFR level at 0.25 years after 
transplant, ml/min 
56.3 (51.4, 62.2) 
  
Population slope (log scale, difference per 
year) 
0.12 (-0.06, 0.31) 
Average percent of eGFR increase per year 13% (-6%, 36%) 
  
SD of random intercepts  0.34 (0.27, 0.42) 
SD of random slopes  0.52 (0.35, 0.76) 
Correlation of random intercept and slope  -0.80 (-0.90, -0.61) 
SD of residuals  0.02 (0.01, 0.08) 
Abbreviations: CI, confidence interval; eGFR, estimated glomerular filtration rate; SD, 
standard deviation. Time was centered at 0.25 years after transplant. The average eGFR 
level was converted from population intercept, and the average percent of eGFR increase 








Table 4. Parameter estimates for pre-transplant variables in 
multivariate regression model 1 
Pre-transplant variables Coefficient (95% CI) 
Age at transplant, year -0.04 (-0.06, -0.02) 
White race 0.17 (0.03, 0.30) 
  
Glomerular CKD diagnosis 0.22 (0.06, 0.38) 
Log eGFR level at study enrollment, 
ml/min|1.73 m2 
0.29 (-0.01, 0.59) 
Annual change in eGFR prior to transplant  0.32 (-0.15, 0.78) 
Log urine protein:creatinine, mg/mg of 
creatinine 
0.02 (-0.03, 0.07) 
  
BMI z-score, standardized by age and gender 0.01 (-0.05, 0.06) 
Height z-score, standardized by age and gender 0.02 (-0.03, 0.07) 
  
Maternal education higher than college -0.02 (-0.15, 0.11) 
Any public insurance  0.09 (-0.05, 0.23) 
Social worker assistance  -0.16 (-0.30, -0.03) 
1 Model was fitted using data from 80 children who contributed eGFR observations within 
1 year after transplant. The coefficients were used to predict eGFR starting values for 72 
children who have no eGFR observations within 1 year. The dependent variable was log-
transformed eGFR starting value. 
 
Table 5. Descriptive statistics of imputed eGFR level at 0.25 
years after transplant by imputation methods  














Abbreviations: eGFR, estimated glomerular filtration rate; MLR, multivariate linear 
regression; IQR, interquartile range. a Restricted to children contributed eGFR in the 
first year after transplant. b Restricted to children who have no eGFR observations 





















Table 6. Descriptive statistics of time from initiation of 
transplantation to eGFR < 45 ml/min|1.73 m2 or censoring, year 
 N Median [IQR] 
Overall event  
(eGFR < 45 ml/min) 
42 2.4 [1.2, 3.6] 
Incident event  24 2.5 [1.8, 4.2] 
Prevalent event 18 1.2 [0.7, 2.8] 
Censored 101 2.8 [1.7, 4.7] 






Type 1: Incident event (n=24) 
 
Figure 1. Examples of eGFR 
trajectories for incident 
event 
● Observed eGFR values 
○ Imputed eGFR starting 
values at 0.25 years from 
transplant 
* eGFR starting value imputed 
by empirical Bayes estimates 
# eGFR starting value 
imputed by MLR  
Red lines represent the 






Type 2: Prevalent event (n=18) 
 
Figure 2. Examples of eGFR 
trajectories for prevalent 
event 
● Observed eGFR values 
○ Imputed eGFR starting 
values at 0.25 years from 
transplant 
* eGFR starting value imputed 
by empirical Bayes estimates 
# eGFR starting value 
imputed by MLR  
Red lines represent the 







Type 3: Censored (n=101) 
 
Figure 3. Examples of eGFR 
trajectories for participants 
who were censored  
● Observed eGFR values 
○ Imputed eGFR starting 
values at 0.25 years from 
transplant 
* eGFR starting value imputed 
by empirical Bayes estimates 
# eGFR starting value 
imputed by MLR  
Red lines represent the 







Type 4: Excluded (n=9) 
 
 
Figure 4. Examples of eGFR 
trajectories for participants 
who were excluded  
● Observed eGFR values 
○ Imputed eGFR starting 
values at 0.25 years from 
transplant 
* eGFR starting value imputed 
by empirical Bayes estimates 
# eGFR starting value 
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